Real-Time Stability Challenges in Biosimilar Development
Real-Time Stability Challenges in Biosimilar Development Overcoming Real-Time Stability Challenges in Biosimilar Development Biosimilars, as highly similar versions of licensed biologics, must demonstrate equivalent safety, efficacy, and quality to their reference products. One of the critical components of biosimilar development is the generation of robust stability data—particularly real-time stability studies that support shelf-life, comparability, and…
Read More “Real-Time Stability Challenges in Biosimilar Development” »